Humana (HUM) Stock Price
Humana Price
Over the last 19 years Humana grew revenue by 9.9% annually, reaching 129.66 B USD. Earnings per share have grown at 6.7% per year over the last 19 years. For Humana, the net margin of 0.9% is down versus 3.5% a few years ago. At today's price the dividend yield works out to roughly 0.88%. The payout ratio is around 36% of earnings. The dividend has grown at 11.7% per year over the past 14 years. The consensus 12-month price target for Humana is 204.00 USD, about 49.1% below where the stock trades today. Of 33 analysts, 10 rate the stock a buy — an overall Hold consensus. The stock trades about 145% above its 52-week low.
Humana stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Humana over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Humana stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Humana's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Humana Price |
|---|---|
| 9/2/2026 | 400.97 USD |
| 9/1/2026 | 394.88 USD |
| 8/31/2026 | 387.07 USD |
| 8/28/2026 | 391.13 USD |
| 8/27/2026 | 391.10 USD |
| 8/26/2026 | 391.06 USD |
| 8/25/2026 | 389.71 USD |
| 8/24/2026 | 381.16 USD |
| 8/21/2026 | 378.88 USD |
| 8/20/2026 | 380.73 USD |
| 8/19/2026 | 377.14 USD |
| 8/18/2026 | 386.31 USD |
| 8/14/2026 | 389.05 USD |
| 8/13/2026 | 384.97 USD |
| 8/12/2026 | 388.83 USD |
| 8/11/2026 | 372.82 USD |
| 8/10/2026 | 386.56 USD |
| 8/7/2026 | 385.00 USD |
| 8/6/2026 | 367.24 USD |
| 8/5/2026 | 364.66 USD |
| 8/4/2026 | 363.37 USD |
| 8/3/2026 | 374.50 USD |
| 7/31/2026 | 363.86 USD |
| 7/30/2026 | 366.66 USD |
| 7/29/2026 | 365.88 USD |
| 7/27/2026 | 385.00 USD |
| 7/23/2026 | 394.50 USD |
| 7/22/2026 | 397.60 USD |
| 7/21/2026 | 404.34 USD |
| 7/20/2026 | 398.20 USD |
Humana Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITB USD |
| EBIT MARGIN% |
| NET INCOMEB USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.29 | 54.41 | 53.80 | 56.94 | 64.93 | 77.19 | 83.65 | 92.92 | 106.44 | 117.81 | 129.66 | 162.51 | 167.82 | 178.95 | 190.01 | 205.76 |
| 11.94 | 0.21 | -1.11 | 5.84 | 14.03 | 18.88 | 8.36 | 11.09 | 14.55 | 10.68 | 10.06 | 25.33 | 3.27 | 6.63 | 6.18 | 8.29 |
| 14.30 | 14.28 | 13.17 | 19.65 | 17.24 | 20.33 | 17.27 | 18.54 | 16.95 | 14.55 | 14.54 | 14.54 | 14.54 | 14.54 | 14.54 | 14.54 |
| 7.77 | 7.77 | 7.09 | 11.19 | 11.19 | 15.69 | 14.45 | 17.23 | 18.05 | 17.15 | 18.85 | 23.63 | 24.40 | 26.02 | 27.63 | 29.92 |
| 2.35 | 1.74 | -1.42 | 3.32 | 3.43 | 4.96 | 3.68 | 3.56 | 3.88 | 2.38 | 3.23 | 2.00 | 3.14 | 4.56 | 5.95 | 6.06 |
| 4.32 | 3.20 | -2.64 | 5.83 | 5.29 | 6.42 | 4.40 | 3.84 | 3.64 | 2.02 | 2.49 | 1.23 | 1.87 | 2.55 | 3.13 | 2.95 |
| 1.28 | 0.61 | 2.45 | 1.68 | 2.71 | 3.37 | 2.93 | 2.81 | 2.49 | 1.21 | 1.19 | 1.10 | 2.01 | 3.33 | 4.20 | 4.30 |
| 11.25 | -51.88 | 298.70 | -31.25 | 60.84 | 24.38 | -12.89 | -4.33 | -11.30 | -51.51 | -1.57 | -7.58 | 82.70 | 65.75 | 26.44 | 2.16 |
| 1.15 | 0.87 | 1.89 | 2.00 | 2.20 | 2.50 | 2.80 | 3.15 | 3.54 | 3.54 | 3.54 | 3.54 | 3.80 | 4.07 | – | – |
| 3.60 | -24.35 | 117.24 | 5.82 | 10.00 | 13.64 | 12.00 | 12.50 | 12.38 | – | – | – | 7.34 | 7.11 | – | – |
| 150.61 | 149.54 | 142.47 | 137.53 | 133.34 | 132.09 | 128.61 | 125.64 | 122.46 | 120.76 | 120.34 | 120.34 | 120.34 | 120.34 | 120.34 | 120.34 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Humana generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Humana retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Humana's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Humana has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Humana's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Humana stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana business model & stock analysis
Humana SWOT Analysis
Strengths
Humana Inc. has established a strong market position in the healthcare industry, particularly in the health insurance sector. This strong presence gives the company a competitive advantage and enhances its brand value.
Humana offers a diverse range of health insurance products and services, including individual and group coverage plans, Medicare, and Medicaid plans. This diverse product portfolio allows the company to cater to a wide range of customer needs.
Weaknesses
A significant portion of Humana's revenue comes from government-sponsored healthcare programs such as Medicare and Medicaid. The company's heavy reliance on these programs exposes it to changes in government regulations and policies, which can impact its financial performance.
Humana's operations are mainly focused in the United States. While this allows the company to have a deep understanding of the local market, it also limits its growth potential in international markets. Expanding into new geographic regions could be a challenge for the company.
Opportunities
The increasing aging population creates a significant opportunity for Humana. With its expertise in Medicare and other senior-focused healthcare plans, the company can benefit from the growing demand for healthcare services among the elderly population.
Rapid advancements in technology present opportunities for Humana to improve its healthcare delivery systems, enhance customer experience, and streamline its operations. Embracing technologies like telemedicine and digital health solutions can give the company a competitive edge.
Threats
The healthcare industry is highly competitive, with multiple players vying for market share. Humana faces competition from other health insurers, as well as from hospitals, healthcare providers, and new entrants to the market. This competitive landscape poses a threat to the company's growth and profitability.
The healthcare industry is heavily regulated, and changes in government regulations and policies can significantly impact Humana's operations and profitability. Moreover, political uncertainty and debates surrounding healthcare reform can create challenges and uncertainties for the company's future.
Humana Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana Segments
Humana Revenue by Segment (1/2)
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana Revenue by Segment (2/2)
3 Years
Max
Details
Humana Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Humana historical P/E ratio, EBIT multiple, and P/S ratio
Humana annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Humana shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana stock splits
Humana Dividend History
20 years of dividend payments
Humana dividend history and estimates
Max
Details
Humana dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Humana forecasts and price targets in September 2026
Analyst Price Targets 2026Humana Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 8/10/2026 | Maintained | Neutral | 59 | |
| 8/5/2026 | Upgrade | UnderweightEqual Weight | 51 | |
| 7/31/2026 | Maintained | Hold | 60 | |
| 7/31/2026 | Maintained | Equal Weight | 57 | |
| 7/30/2026 | Maintained | Neutral | 46 | |
| 7/30/2026 | Downgrade | OutperformMarket Perform | 65 | |
| 7/30/2026 | Maintained | Buy | 30 | |
| 7/30/2026 | Upgrade | In LineOutperform | 62 | |
| 7/14/2026 | Maintained | Hold | – | |
| 7/14/2026 | Maintained | Hold | 60 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Humana Earnings Calls
Humana Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 7/29/2026 | 7.27USD | - | 41.02 BUSD | - | 2026 Q2 |
| 4/29/2026 | 10.13USD | - | 39.76 BUSD | - | 2026 Q1 |
| 2/11/2026 | -4.05USD | - | 32.40 BUSD | - | 2025 Q4 |
| 4/24/2024 | 10.38USD | - | 28.86 BUSD | - | 2024 Q1 |
| 1/30/2024 | 2.20USD | - | 25.79 BUSD | - | 2023 Q4 |
| 7/25/2023 | 8.99USD | - | 25.88 BUSD | - | 2023 Q2 |
| 4/25/2023 | 8.75USD | - | 26.18 BUSD | - | 2023 Q1 |
| 1/31/2023 | 1.49USD | - | 22.82 BUSD | - | 2022 Q4 |
| 11/2/2022 | 6.35USD | - | 23.10 BUSD | - | 2022 Q3 |
| 7/27/2022 | 7.75USD | - | 23.82 BUSD | - | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Humana stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Humana shareholder structure
| % | Name |
|---|---|
11.83096% | |
9.47994% | |
9.40478% | |
8.49567% | |
6.52958% | |
5.42290% |
Humana Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
9.50% | SEC ↗ | |
9.40% | SEC ↗ | |
9.40% | SEC ↗ | |
8.83% | SEC ↗ | |
8.80% | SEC ↗ | |
8.10% | SEC ↗ | |
7.79% | SEC ↗ | |
7.70% | SEC ↗ | |
7.60% | SEC ↗ | |
7.60% | SEC ↗ |
Humana Executives and Management Board
22 members · avg. age 56 · 27 % women
Mr. David Dintenfass (54)
President - Enterprise Growth
18.06 M USD
Management
Mr. James Rechtin (54)
President, Chief Executive Officer, Director · since 2024
Dr. Sanjay Shetty (51)
President - CenterWell
Mr. George Renaudin (56)
President - Insurance
Mr. Joseph Ventura (47)
Chief Legal Officer
Ms. Celeste Mellet (48)
Chief Financial Officer
Ms. Michelle O'Hara (49)
Chief Human Resources Officer
Board of Directors
Mr. Kurt Hilzinger (64)
Independent Chairman of the Board
Ms. Karen Katz (68)
Independent Director
Dr. Wayne Frederick (53)
Independent Director
Mr. Frank D'amelio (67)
Independent Director
Mr. Jorge Mesquita (63)
Independent Director
Ms. Marcy Klevorn (65)
Independent Director
Humana Supply Chain
Humana Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | Tivity Health | 0.41 | 0.41 | 0.46 | |
| 2 | 0.17 | 0.13 | 0.44 | ||
| 3 | 0.71 | 0.25 | 0.42 | ||
| 4 | 0.61 | 0.18 | 0.41 | ||
| 5 | -0.32 | -0.13 | 0.39 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | Signify Health A | 0.44 | 0.07 | — | |
| 2 | 0.30 | — | — | ||
| 3 | -0.16 | — | — | ||
| 4 | -0.08 | 0.12 | — | ||
| 5 | 0.09 | -0.05 | — |
Frequently asked questions about Humana
The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.
Humana Inc is primarily active in the healthcare industry. With a focus on offering a wide range of health insurance products and services, Humana serves individuals, employers, military service members, and their families. The company provides various medical and specialty health products, including Medicare Advantage plans, prescription drug plans, dental, vision, and wellness programs. With an extensive network of healthcare providers, Humana aims to improve the health and well-being of its members by delivering personalized and comprehensive healthcare solutions. As one of the leading healthcare companies, Humana Inc plays a crucial role in the provision of accessible and quality healthcare services.
The main competitors of Humana Inc in the market include UnitedHealth Group Incorporated, Anthem, Inc., and CVS Health Corporation.
Humana Inc is a leading healthcare company founded in 1961 and headquartered in Louisville, Kentucky. With a rich history spanning over five decades, Humana has emerged as a trusted name in the industry. Originally a nursing home business, Humana quickly expanded its operations to provide comprehensive health insurance services. Today, it offers a wide range of healthcare products and services, including Medicare and Medicaid plans, commercial health insurance, and specialty benefits. Through strategic acquisitions and partnerships, Humana has consistently grown its presence, providing innovative and accessible healthcare solutions to millions of customers across the United States. The company's commitment to customer-centric care and its extensive industry experience have solidified Humana Inc's position as a prominent player in the healthcare sector.
Humana Inc, a renowned healthcare company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, highlighting its position among the top-ranked businesses in the United States. Additionally, Humana Inc has consistently expanded its presence and diversified its offerings, successfully establishing itself as a leading provider of health insurance, wellness programs, and healthcare services. The company has also been recognized for its commitment to innovation, earning accolades for its progressive approach to healthcare delivery. Humana Inc's dedication to improving customer satisfaction and promoting healthy living has contributed to its widespread success in the industry.
Humana Inc is primarily present in the United States.
Humana Inc is committed to enhancing the well-being of people and making healthcare more accessible. The company's corporate philosophy revolves around delivering value-based care, focusing on the whole person, and improving the health outcomes of its members. Humana prioritizes innovation and technology to provide personalized and affordable healthcare solutions. With a focus on preventive care and wellness programs, Humana aims to empower individuals to live healthier lives. By fostering a culture of inclusion, collaboration, and integrity, Humana strives to be a trusted partner for its members, employees, and communities it serves.
Analysts currently set an average price target of 222.29 USD for the Humana stock (median: 204.00 USD), implying -44.6 % versus the latest price. The consensus is based on 33 analyst ratings.
33 analysts currently rate the Humana stock: 10 recommend buying, 21 holding and 2 selling. For 2026, analysts expect Humana to generate revenue of 162.51 B USD and earnings per share of 9.13 USD.
Converted at the current exchange rate, the Humana share trades at 346.18 EUR (400.97 USD).
The Humana share (HUM) is listed on 7 stock exchanges, including: NYSE (HUM), Frankfurt (HUM.F), München (HUM.MU), Düsseldorf (HUM.DU), London (0J6Z.L), London (0J6Z.L), SIX (Zürich) (HUM.SW).
Humana Inc is a global healthcare company based in Louisville, Kentucky. It offers various products and services in healthcare, health insurance, and lifelong health solutions. They provide insurance for different areas such as medical, dental, vision, and travel. Additionally, they have specialized insurance plans for seniors and people with chronic illnesses. Humana also operates clinics and medical centers, offering a wide range of medical services including prevention, diagnosis, and treatment. They invest in research and development of medical technologies to improve healthcare. In terms of lifelong health solutions, Humana has programs like Humana GO365 that reward healthy behaviors. They also operate pharmacies and offer specialized pharmacy services. Humana's business model aims to provide tailored health solutions and insurance products to meet each customer's needs.
The expected revenue of Humana is 162.51 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Humana is 1.10 B USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Humana is currently 43.91. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Humana stock.
The price-to-sales ratio (P/S) of Humana is currently 0.30. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Humana stock.
The Eulerpool Quality Score for Humana is 5/10.
The ISIN of Humana is US4448591028. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Humana is 856584. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Humana is HUM. The ticker symbol is used to trade Humana shares on the stock exchange.
Over the past 12 months, Humana paid a dividend of 3.54 USD . This corresponds to a dividend yield of about 0.88 %. For the coming 12 months, Humana is expected to pay a dividend of 3.80 USD.
The current dividend yield of Humana is 0.88 %.
Humana pays a dividend, distributed in the months of , , , .
Humana paid dividends every year for the past 15 years.
For the upcoming 12 months, dividends amounting to 3.80 USD are expected. This corresponds to a dividend yield of 0.95 %.
Humana is assigned to the 'Health' sector.
To receive the latest dividend of Humana from amounting to 0.89 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, Humana distributed 3.54 USD as dividends.
The dividends of Humana are distributed in USD.
Humana stock
Humana Ticker
Humana FIGI
All fundamentals and in-depth analysis of Humana
Our stock analysis for Humana stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humana. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.